Brief: Glaukos Submits New Drug Application To U.S. FDA For IDose TR
27/02/2023 12:09
Feb 27 (Reuters) - Glaukos Corp GKOS.N :
* GLAUKOS SUBMITS NEW DRUG APPLICATION TO U.S. FDA FOR IDOSE
TR
Source text for Eikon: ID:nBw4hYPyha
Further company coverage: GKOS.N
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Glaukos
See all newsGlaukos says late-stage eye disease treatment shows lasting benefits after single dose
Brief: Glaukos Announces Positive Three-Year Epioxa® Results Demonstrating Durable Clinical Outcomes In Keratoconus
US RESEARCH ROUNDUP-Boeing, Twilio, WP Carey
U.S. RESEARCH ROUNDUP-Equinix, Meta, S&P Global
Glaukos Corp reports results for the quarter ended June 30 - Earnings Summary